tradingkey.logo

Dr Reddy's Laboratories Ltd

RDY
14.200USD
+0.260+1.87%
收盤 12/19, 16:00美東報價延遲15分鐘
11.82B總市值
17.32本益比TTM

Dr Reddy's Laboratories Ltd

14.200
+0.260+1.87%

關於 Dr Reddy's Laboratories Ltd 公司

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Dr Reddy's Laboratories Ltd簡介

公司代碼RDY
公司名稱Dr Reddy's Laboratories Ltd
上市日期Jan 01, 1986
CEOAghanian (Patrick)
員工數量27811
證券類型Depository Receipt
年結日Jan 01
公司地址8-2-337, Road No.3 Banjara Hills
城市HYDERABAD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家India
郵編500-034
電話914049002900
網址https://www.drreddys.com/
公司代碼RDY
上市日期Jan 01, 1986
CEOAghanian (Patrick)

Dr Reddy's Laboratories Ltd公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Sanjiv Soshil Mehta
Mr. Sanjiv Soshil Mehta
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phanimitra (Phani) B
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
Chief Digital and Information Officer
--
--
Mr. Mannam Venkata Narasimham
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Richa Periwal
Ms. Richa Periwal
Investor Relations
Investor Relations
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. K. Randhir Singh
Mr. K. Randhir Singh
Compliance Officer, Company Secretary, Head - CSR
Compliance Officer, Company Secretary, Head - CSR
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Chan (Penny) Wan
Ms. Chan (Penny) Wan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Arun Madhavan Kumar
Mr. Arun Madhavan Kumar
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Sanjiv Soshil Mehta
Mr. Sanjiv Soshil Mehta
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phanimitra (Phani) B
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
Chief Digital and Information Officer
--
--
Mr. Mannam Venkata Narasimham
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Richa Periwal
Ms. Richa Periwal
Investor Relations
Investor Relations
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
由於公司未披露,未能獲取相關數據
地區USD
名稱
營收
佔比
United States
427.18M
42.77%
Other
309.06M
30.94%
India
179.87M
18.01%
Russia
82.79M
8.29%
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 12月11日 週四
更新時間: 12月11日 週四
持股股東
股東類型
持股股東
持股股東
佔比
Robeco Institutional Asset Management B.V.
1.57%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.81%
其他
94.20%
持股股東
持股股東
佔比
Robeco Institutional Asset Management B.V.
1.57%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.81%
其他
94.20%
股東類型
持股股東
佔比
Investment Advisor
6.56%
Investment Advisor/Hedge Fund
4.39%
Hedge Fund
1.20%
Research Firm
1.12%
Pension Fund
0.33%
Family Office
0.19%
Family Office
0.10%
Family Office
0.10%
Bank and Trust
0.08%
其他
85.93%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
516
112.51M
13.51%
-15.88M
2025Q2
504
118.15M
14.19%
-12.22M
2025Q1
506
114.84M
13.80%
-17.55M
2024Q4
478
124.61M
14.96%
-2.62M
2024Q3
462
118.95M
14.28%
-16.57M
2024Q2
445
126.18M
15.15%
-4.51M
2024Q1
437
124.83M
14.99%
-5.58M
2023Q4
427
125.49M
15.07%
-4.37M
2023Q3
406
119.09M
14.31%
-4.07M
2023Q2
397
109.36M
13.16%
-3.97M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Robeco Institutional Asset Management B.V.
12.16M
1.46%
+1.45M
+13.56%
Jun 30, 2025
Aperio Group, LLC
9.26M
1.11%
+2.30M
+33.13%
Jun 30, 2025
RBC Global Asset Management (UK) Limited
9.33M
1.12%
+281.97K
+3.12%
Jun 30, 2025
Renaissance Technologies LLC
9.01M
1.08%
-182.10K
-1.98%
Jun 30, 2025
Aikya Investment Management Limited
6.35M
0.76%
+154.60K
+2.49%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
5.40M
0.65%
-64.08K
-1.17%
Jun 30, 2025
The Vanguard Group, Inc.
4.98M
0.6%
-27.59K
-0.55%
Jun 30, 2025
Parametric Portfolio Associates LLC
4.28M
0.51%
+631.20K
+17.32%
Jun 30, 2025
State Street Investment Management (US)
4.19M
0.5%
+131.99K
+3.25%
Jun 30, 2025
BNP Paribas Securities Corp. North America
4.01M
0.48%
-569.44K
-12.42%
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
National Security Emerging Markets Index ETF
0.91%
Invesco S&P Emerging Markets Low Volatility ETF
0.39%
Lattice Hartford Multifactor Emerging Markets ETF
0.33%
DFA Dimensional Emerging Markets Value ETF
0.22%
ActivePassive International Equity ETF
0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
0.13%
SPDR Portfolio Emerging Markets ETF
0.12%
Avantis Emerging Markets Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.12%
查看更多
National Security Emerging Markets Index ETF
佔比0.91%
Invesco S&P Emerging Markets Low Volatility ETF
佔比0.39%
Lattice Hartford Multifactor Emerging Markets ETF
佔比0.33%
DFA Dimensional Emerging Markets Value ETF
佔比0.22%
ActivePassive International Equity ETF
佔比0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
佔比0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
佔比0.13%
SPDR Portfolio Emerging Markets ETF
佔比0.12%
Avantis Emerging Markets Equity ETF
佔比0.12%
SP Funds S&P World (ex-US) ETF
佔比0.12%

分紅派息

近5年累計派現 332.70M 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
May 09, 2024
RDY.NB Final Cash Dividend of gross USD 0.476153 paid on Aug 12, 2024 going ex on Jul 30, 2024
Jul 15, 2024
Aug 12, 2024
Jul 30, 2024
May 11, 2023
RDY.NB Final Cash Dividend of gross USD 0.482608 paid on Aug 11, 2023 going ex on Jul 28, 2023
Jul 10, 2023
Aug 11, 2023
Jul 28, 2023
May 24, 2022
RDY.NB Final Cash Dividend of gross USD 0.378434 paid on Aug 12, 2022 going ex on Aug 01, 2022
Jul 11, 2022
Aug 12, 2022
Aug 01, 2022
Jun 16, 2021
RDY.NB Final Cash Dividend of gross USD 0.336485 paid on Aug 11, 2021 going ex on Jul 30, 2021
Jul 09, 2021
Aug 11, 2021
Jul 30, 2021
Jun 26, 2020
RDY.NB Final Cash Dividend of gross USD 0.333364 paid on Aug 17, 2020 going ex on Jul 10, 2020
Jul 13, 2020
Aug 17, 2020
Jul 10, 2020

拆合股

公告日期
類型
比率
Oct 07, 2024
Split
1→5
公告日期
類型
比率
Oct 07, 2024
Split
1→5

常見問題

Dr Reddy's Laboratories Ltd的前五大股東是誰?

Dr Reddy's Laboratories Ltd的前五大股東如下:
Robeco Institutional Asset Management B.V.
持有股份:12.16M
佔總股份比例:1.46%。
Aperio Group, LLC
持有股份:9.26M
佔總股份比例:1.11%。
RBC Global Asset Management (UK) Limited
持有股份:9.33M
佔總股份比例:1.12%。
Renaissance Technologies LLC
持有股份:9.01M
佔總股份比例:1.08%。
Aikya Investment Management Limited
持有股份:6.35M
佔總股份比例:0.76%。

Dr Reddy's Laboratories Ltd的前三大股東類型是什麼?

Dr Reddy's Laboratories Ltd 的前三大股東類型分別是:
Robeco Institutional Asset Management B.V.
Aperio Group, LLC
RBC Global Asset Management (UK) Limited

有多少機構持有Dr Reddy's Laboratories Ltd(RDY)的股份?

截至2025Q3,共有516家機構持有Dr Reddy's Laboratories Ltd的股份,合計持有的股份價值約為112.51M,占公司總股份的13.51% 。與2025Q2相比,機構持股有所增加,增幅為-0.68%。

哪個業務部門對Dr Reddy's Laboratories Ltd的收入貢獻最大?

在FY2026Q1,--業務部門對Dr Reddy's Laboratories Ltd的收入貢獻最大,創收--,占總收入的--% 。
KeyAI